Newsletters
Welcome to the Spring 2025 edition of the TEDct Newsletter.
This issue brings together key updates, educational resources, and personal experiences from the TED community. Highlights include:
- The latest on the NICE consultation for Teprotumumab, the first TED drug under review for NHS approval
- A webinar partnership with Moorfields Eye Hospital on advances in TED treatment, now available to watch online
- Announcement of the TEDct Prize at the British Oculoplastic Surgical Society, awarded for important new research on radioiodine therapy and TED
- The Tomlin Guide to Prisms – a practical guide for managing double vision, written for both patients and professionals
- Continued growth of our Facebook support forum, now with over 1,700 members
- TEDct joins the Society for Endocrinology as an official patient support group
- A powerful personal story from a member living with Hashimoto’s and TED
We hope this newsletter provides helpful insights and support. Thank you for being part of the TEDct community.
Would you like to be sent the TEDct newlsetter?
You can download our latest newsletter below — no signup needed.
However to receive future editions straight to your inbox please do subscribe to become a TEDct member.
TEDct membership is FREE.
Subscribe and become a TEDct member.